Search

Exploring and understanding the structure‐mechanical property relations in hierarchical graphene assemblies is crucial for optimizing their mechanical properties and developing new functionalities, as the tensile strength is two orders of magnitude degradation from pristine graphene to graphene assemblies. Yet, quantifying the strength degradation across multiscale is a challenge due to the complex hierarchical structures. Thus, key structures and dominated factors at different lengthscales that affect the mechanical properties of graphene assemblies should be extracted for the reasonable unveiling of this problem. In this study, the multiscale mechanical degradation of graphene assemblies through practical microstructure‐guided multiscale modeling is characterized. Combining with experimental observations, three representative models are developed to study the mechanical behaviors of graphene assemblies at different lengthscales. Then, the dominated factors affecting the strength at these lengthscales are identified, that is the defects in monolayer graphene, tension‐shear load transfer for stacked graphene, and uniformity of graphene assemblies. Based on the simulation results, the structure‐strength relation of graphene assemblies is given, and practical strategies are proposed followed by experimental realization, to significantly improve the mechanical properties of graphene‐based nanocomposites. [ABSTRACT FROM AUTHOR]

Motile cilia on the cell surface generate movement and directional fluid flow that is crucial for various biological processes. Dysfunction of these cilia causes human diseases such as sinopulmonary disease and infertility. Here, we show that Ccdc108, a protein linked to male infertility, has an evolutionarily conserved requirement in motile multiciliation. Using Xenopus laevis embryos, Ccdc108 is shown to be required for the migration and docking of basal bodies to the apical membrane in epidermal multiciliated cells (MCCs). We demonstrate that Ccdc108 interacts with the IFT‐B complex, and the ciliation requirement for Ift74 overlaps with Ccdc108 in MCCs. Both Ccdc108 and IFT‐B proteins localize to migrating centrioles, basal bodies, and cilia in MCCs. Importantly, Ccdc108 governs the centriolar recruitment of IFT while IFT licenses the targeting of Ccdc108 to the cilium. Moreover, Ccdc108 is required for the centriolar recruitment of Drg1 and activated RhoA, factors that help establish the apical actin network in MCCs. Together, our studies indicate that Ccdc108 and IFT‐B complex components cooperate in multiciliogenesis. Synopsis: Ccdc108, an axonemal central pair apparatus protein, localizes to centrioles and regulates accumulation of IFT‐B complex proteins and PCP‐associated actin cytoskeletal factors required for migration and docking of centrioles to the cell surface during multiciliogenesis. Ccdc108 is evolutionarily conserved to regulate multiciliogenesis.Ccdc108 interacts with IFT‐B components, which licenses the targeting of Ccdc108 to the cilium.Ccdc108 localizes to migrating centrioles where it governs the centriolar accumulation of IFT‐B components during early multiciliogenesis.Ccdc108 and IFT‐B complex components cooperate in regulating the centriolar recruitment of PCP‐associated cytoskeletal proteins for the establishment of the apical actin network. [ABSTRACT FROM AUTHOR]

Graphene fiber (GF), a macroscopic one‐dimensional assembly of individual graphene sheets, promises both extraordinary mechanical performance and superior multifunctionality. However, the properties of graphene fiber are still limited due to the unfavorable crystalline structures, especially induced by wrinkled conformations of graphene. A plasticization spinning strategy is presented to achieve GF with both high mechanical strength and electrical/thermal conductivity. Adjusting the interlayer space from 1.2 to 1.8 nm by intercalating proper plasticizers to adjacent graphene oxide sheets enables graphene oxide fibers to achieve a 580% enhanced deformable plasticity. Such a plasticization spinning flattens random graphene wrinkles, and regulates sheets with high order and stacking density, thereby forming large crystallite domains. The GF exhibits all around record performance including mechanical strength (3.4 GPa), electrical conductivity (1.19 × 106 S m−1), and thermal conductivity (1480 W m−1 K−1). The optimally crystalline GF with the integration of benchmark overall properties and scalable fabrication is likely to be attractive and competitive in future industrial applications. [ABSTRACT FROM AUTHOR]

The unique, plate-like morphology of hydroxyapatite (HAP) nanocrystals in bone lends to the hierarchical structure and functions of bone. Proteins enriched in phosphoserine (Ser-OPO3) and glutamic acid (Glu) residues have been proposed to regulate crystal morphology; however, the atomic-level mechanisms remain unclear. Previous molecular dynamics studies addressing biomineralization have used force fields with limited benchmarking, especially at the water/mineral interface, and often limited sampling for the binding free energy profile. Here, we use the umbrella sampling/weighted histogram analysis method to obtain the adsorption free energy of Ser-OPO3 and Glu on HAP (100) and (001) surfaces to understand organic-mediated crystal growth. The calculated organic-water-mineral interfacial energies are carefully benchmarked to density functional theory calculations, with explicit inclusion of solvating water molecules around the adsorbate plus the Poisson-Boltzmann continuum model for long-range solvation effects. Both amino acids adsorb more strongly on the HAP (100) face than the (001) face. Growth rate along the [100] direction should then be slower than in the [001] direction, resulting in plate-like crystal morphology with greater surface area for the (100) than the (001) face, consistent with bone HAP crystal morphology. Thus, even small molecules are capable of regulating bone crystal growth by preferential adsorption in specific directions. Furthermore, Ser-OPO3 is a more effective growth modifier by adsorbing more strongly than Glu on the (100) face, providing one possible explanation for the energetically expensive process of phosphorylation of some proteins involved in bone biomineralization. The current results have broader implications for designing routes for biomimetic crystal synthesis. © 2013 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]

The multikinase inhibitor sorafenib is the first oral agent to show activity against human hepatocellular carcinoma (HCC). Apoptosis has been shown to be induced in HCC by several agents, including sorafenib as well as by the naturally occurring K vitamins (VKs). As few nontoxic agents have activity against HCC growth, we evaluated the activity of sorafenib and VKs, both independently and together on the growth of HCC cells in vitro and in vivo. We found that when VK was combined with sorafenib, the concentration of sorafenib required for growth inhibition was substantially reduced. Conversely, VK enhanced sorafenib effects in several HCC cell lines on growth inhibition. Growth could be inhibited at doses of VK plus sorafenib that were ineffective with either agent alone, using vitamins K1, K2 and K5. Combination of VK1 plus sorafenib induced apoptosis on FACS, TUNEL staining and caspase activation. Phospho-extracellular signal-regulated kinase (ERK) levels were decreased as was myeloid cell leukemia sequence 1 (Mcl-1), an ERK target. Sorafenib alone inhibited growth of transplantable HCC in vivo. At subeffective sorafenib doses in vivo, addition of VK1 caused major tumor regression, with decreased phospho-ERK and Mcl-1 staining. Thus, combination of VK1 plus sorafenib strongly induced growth inhibition and apoptosis in rodent and human HCC and inhibited the RAF/mitogen-activated protein kinase kinase/ERK pathway. VK1 alone activated PKA, a mediator of inhibitory Raf phosphorylation. Thus, each agent can antagonize Raf: sorafenib as a direct inhibitor and VK1 through inhibitory Raf phosphorylation. As both agents are available for human use, the combination has potential for improving sorafenib effects in HCC. [ABSTRACT FROM AUTHOR]

Abstract: Most hepatomas have a defect in prothrombin carboxylation, and can secrete under-carboxylated prothrombin or des-γ-carboxy-prothrombin (DCP), the function of which is unknown. We considered that the prothrombin-DCP axis might also be involved in growth control. Hepatocytes and hepatoma cells were treated with prothrombin and DNA synthesis and cytoskeletal changes were studied. Prothrombin inhibited DNA synthesis in hepatocytes on fibronectin, but not collagen matrix. Hepatoma cell lines were not inhibited. We found that hepatoma cell matrix conferred resistance to hepatocytes. Prothrombin decreased fibronectin but not collagen amounts, but only in the presence of hepatocytes and not hepatoma cells, indicating that it has a differential action on matrix proteins. It also caused changes in cell shape and actin depolymerization. In vivo, there was a decrease in plasma prothrombin activity after a partial hepatectomy (PH), concomitant with the peak of DNA synthesis in the hepatocytes at 24h after PH. Injection of warfarin at the time of PH, further inhibited PT activity and enhanced this 24h peak of DNA synthesis. Furthermore, repeated injection of prothrombin lowered the peak DNA synthesis after PH. The data support the hypothesis that prothrombin can act as a hepatocyte growth inhibitor, likely at the level of fibronectin loss and result in cytoskeletal changes. Hepatomas resist this action, possibly due to their different matrix proteins. This represents a novel mechanism for growth regulation and provides a possible biological significance for the tumor marker DCP. [Copyright &y& Elsevier]